LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC decreased its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 10.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 235,076 shares of the medical instruments supplier’s stock after selling 26,230 shares during the period. LeMaitre Vascular makes up approximately 1.2% of Rice Hall James & Associates LLC’s holdings, making the stock its 23rd largest position. Rice Hall James & Associates LLC owned approximately 1.05% of LeMaitre Vascular worth $21,660,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the business. New York State Teachers Retirement System boosted its stake in shares of LeMaitre Vascular by 1.2% during the fourth quarter. New York State Teachers Retirement System now owns 8,189 shares of the medical instruments supplier’s stock worth $755,000 after buying an additional 100 shares during the period. Shaker Investments LLC OH raised its holdings in LeMaitre Vascular by 0.8% during the fourth quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier’s stock worth $1,285,000 after purchasing an additional 112 shares in the last quarter. Sanctuary Advisors LLC raised its holdings in LeMaitre Vascular by 6.0% during the fourth quarter. Sanctuary Advisors LLC now owns 2,065 shares of the medical instruments supplier’s stock worth $207,000 after purchasing an additional 117 shares in the last quarter. Glenmede Trust Co. NA raised its holdings in LeMaitre Vascular by 1.3% during the third quarter. Glenmede Trust Co. NA now owns 10,512 shares of the medical instruments supplier’s stock worth $976,000 after purchasing an additional 136 shares in the last quarter. Finally, Summit Global Investments raised its holdings in LeMaitre Vascular by 2.4% during the third quarter. Summit Global Investments now owns 6,192 shares of the medical instruments supplier’s stock worth $575,000 after purchasing an additional 146 shares in the last quarter. Institutional investors and hedge funds own 84.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Barrington Research increased their price target on shares of LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a report on Friday, November 1st. StockNews.com cut shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Friday, December 13th. Wells Fargo & Company assumed coverage on shares of LeMaitre Vascular in a report on Thursday, February 13th. They set an “equal weight” rating and a $95.00 price target for the company. Finally, Oppenheimer reissued an “outperform” rating and set a $93.00 price target (up from $90.00) on shares of LeMaitre Vascular in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $94.63.

LeMaitre Vascular Trading Up 1.7 %

Shares of LeMaitre Vascular stock opened at $98.65 on Tuesday. LeMaitre Vascular, Inc. has a 12-month low of $59.87 and a 12-month high of $109.58. The stock has a market cap of $2.22 billion, a PE ratio of 53.91, a price-to-earnings-growth ratio of 2.19 and a beta of 0.96. The company has a 50-day moving average of $95.97 and a two-hundred day moving average of $93.74.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.